Crinetics Pharmaceuticals (NASDAQ:CRNX) Releases Earnings Results, Misses Estimates By $0.01 EPS

Crinetics Pharmaceuticals (NASDAQ:CRNX – Get Free Report) released its quarterly earnings results on Wednesday. The company reported ($0.90) earnings per share for the quarter, missing the consensus estimate of ($0.89) by ($0.01), Briefing.com reports. Crinetics Pharmaceuticals had a negative net margin of 4,223.27% and a negative return on equity of 57.04%. The business’s revenue for […]

Related Keywords

Dana Pizzuti ,Robertw Baird ,Stephenf Betz ,Cantor Fitzgerald ,Crinetics Pharmaceuticals ,Blackrock Inc ,Metlife Investment Management ,Group One Trading ,Securities Exchange Commission ,News Ratings For Crinetics Pharmaceuticals Daily ,Crinetics Pharmaceuticals Trading Down ,Crinetics Pharmaceuticals Company Profile ,Institutional Investors Weigh In On Crinetics Pharmaceuticals ,Jpmorgan Chase Co ,Crinetics Pharmaceuticals Inc ,Earnings History For Crinetics Pharmaceuticals ,Get Free Report ,Pharmaceuticals Trading Down ,Exchange Commission ,Life Investment Management ,Crinetics Pharmaceuticals Daily ,